Milestone Pharmaceuticals Inc. (MIST) Free cash flow 2018–2025
Milestone Pharmaceuticals Inc. (MIST) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$49.3MFY2025 · since FY2018: -$21.1M → -$49.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.3M | -70.8% |
| FY2024 | -$28.9M | +37.9% |
| FY2023 | -$46.5M | +11.8% |
| FY2022 | -$52.7M | — |
| FY2019 | -$51.6M | -145.0% |
| FY2018 | -$21.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice